Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Revenue (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Revenue for 15 consecutive years, with $26.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue rose 21.39% year-over-year to $26.3 million, compared with a TTM value of $101.9 million through Sep 2025, up 30.52%, and an annual FY2024 reading of $86.7 million, up 33.36% over the prior year.
  • Revenue was $26.3 million for Q3 2025 at Sanara MedTech, up from $25.8 million in the prior quarter.
  • Across five years, Revenue topped out at $26.3 million in Q3 2025 and bottomed at $5.0 million in Q1 2021.
  • Average Revenue over 5 years is $15.6 million, with a median of $15.8 million recorded in 2023.
  • The sharpest move saw Revenue fell 22.83% in 2021, then surged 123.98% in 2022.
  • Year by year, Revenue stood at $7.0 million in 2021, then skyrocketed by 117.76% to $15.3 million in 2022, then increased by 15.5% to $17.7 million in 2023, then surged by 48.7% to $26.3 million in 2024, then rose by 0.01% to $26.3 million in 2025.
  • Business Quant data shows Revenue for SMTI at $26.3 million in Q3 2025, $25.8 million in Q2 2025, and $23.4 million in Q1 2025.